Drug Development

Articles

CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.

CordenPharma to Manufacture Lipid Excipients for Moderna's Vaccine

Advent manufactured the vaccine doses for the Phase 2/3 clinical trial. 

Advent Delivers Doses of COVID-19 Vaccine Candidate for University of Oxford Clinical Trial

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

The White House looks to bring in credible experts for its Operation Warp Speed initiative to advance therapies and vaccines to combat the coronavirus pandemic. 

FDA Leadership Shifts to Advance COVID-19 Treatments

The company announced that participants have enrolled in a Phase 1/2 clinical trial of its COVID-19 vaccine candidate, NVX‑CoV2373, a prefusion protein made using Novavax’s proprietary nanoparticle technology.

Novavax Announces First Participants in Coronavirus Vaccine Clinical Trial

Funding from the US government could lead to 300 million coronavirus vaccine doses by October 2020.

BARDA Commits $1.2 Billion to AstraZeneca Vaccine Program

The companies have formed a collaboration to develop a novel human recombinant protein as a therapeutic candidate against COVID-19.


Airway Therapeutics, Celonic Group Partner on New COVID-19 Therapeutic

CanSinoBIO will license-in Precision NanoSystems' proprietary RNA vaccine platform technology while the latter leads the development of the RNA vaccine formulation.

CanSino Biologics, Precision NanoSystems to Co-develop COVID-19 RNA Vaccine

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.

BARDA Funds US-based Drug Manufacturing Initiative

Participants in two dosing cohorts in Moderna’s mRNA-1273 study reached or exceeded neutralizing antibody titers generally seen in convalescent sera.

mRNA Vaccine Shows Positive Interim Phase I Results

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.


Formulation and Drug Delivery